Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 1-A Offering statement
- PART II AND III Preliminary Offering Circular
- EX1A-3 HLDRS RTS Loan Termination Agreement Dated June 1, 2021 Between the Company and Emerald Health Sciences Inc
- EX1A-4 SUBS AGMT Form of Subscription Agreement
- EX1A-11 CONSENT Consent of Deloitte & Touche LLP
- EX1A-12 OPN CNSL Opinion of Greenberg Traurig, P.a.
Associated filings
- 6 Oct 21 1-A/A Offering $50M in Equity
-
26 Jul 21 1-A Offering $50M in Equity
Emerald Health Pharmaceuticals similar filings
Filing view
External links
Exhibit 11.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the use in this Registration Statement on Form 1-A of our report dated April 30, 2021 relating to the financial statements of Emerald Health Pharmaceuticals Inc.
/s/ DELOITTE & TOUCHE LLP
San Diego, California
July 26, 2021